Coronary Heart Disease and Iron Status: Meta-Analyses of Prospective Studies

Cited by (226)

Items 101–200 of 226

1. Excessive Body Iron Stores Are Not Associated with Risk of Coronary Heart Disease in Women
   Qi Sun, Jing Ma, Nader Rifai, Oscar H. Franco, Kathryn M. Rexrode, Frank B. Hu · 2008 · Journal of Nutrition
2. The association of biomarkers of iron status with peripheral arterial disease in US adults
   Andy Menke, José Manuel Fernández‐Real, Paul Muntner, Eliseo Güallar · 2009 · BMC Cardiovascular Disorders
3. Do body iron stores increase the risk of developing coronary heart disease?
   Christopher T. Sempos · 2002 · American Journal of Clinical Nutrition
4. Is serum ferritin within the reference range a risk predictor of cardiovascular disease? A population-based, long-term study comprising 2874 subjects
   Nele Friedrich, Nils Thorm Milman, Henry Völzke, Allan R Linneberg, Torben Jørgensen · 2009 · British Journal Of Nutrition
5. The association of biomarkers of iron status with mortality in US adults
   Andy Menke, Paul Muntner, José Manuel Fernández‐Real, Eliseo Güallar · 2011 · Nutrition Metabolism and Cardiovascular Diseases
6. The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease
   Stewart Campbell, D. Keith George, S D Robb, R Spooner, T A McDonagh, H J Dargie, Peter R. Mills · 2003 · Heart
7. Iron status in Danish men 1984–94: a cohort comparison of changes in iron stores and the prevalence of iron deficiency and iron overload
   Nils Thorm Milman, Keld‐Erik Byg, Lars Ovesen, Marianne Kirchhoff, Kirsten Schultz‐Larsen Jürgensen · 2002 · European Journal Of Haematology
8. Effect of Dexrazoxane on Homocysteine-Induced Endothelial Dysfunction in Normal Subjects
   Zheng, Haoyi, Dimayuga, Clarito, Hudaihed, Alhakam, Katz, Stuart D. · 2002 · Arteriosclerosis, Thrombosis, and Vascular Biology
9. Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress–related disease outcomes
   Duk‐Hee Lee, Leo R. Zacharski, David R. Jacobs · 2006 · American Heart Journal
10. Leukocyte telomere length: the telomere tale continues
    Abraham Aviv · 2009 · American Journal of Clinical Nutrition
11. Prognostic Evaluation of Catalytic Iron in Patients With Acute Coronary Syndromes
    Dylan L Steen, Christopher Paul Cannon, Suhas S. Lele, Mohan M. Rajapurkar, Banibrata N. Mukhopadhyay, Benjamin M. Scirica, Sabina A. Murphy, David A. Morrow · 2013 · Clinical Cardiology
12. Risk Factors for Near-Term Myocardial Infarction in Apparently Healthy Men and Women
    Børge Grønne Nordestgaard, Aram S. Adourian, J Freiberg, Yu Feng Guo, Pieter Muntendam, Erling Falk · 2010 · Clinical Chemistry
13. Serum Chelatable Redox-Active Iron Is an Independent Predictor of Mortality After Myocardial Infarction in Individuals With Diabetes
    Mahmoud Sulieman, Rabea Asleh, Zvi Ioav Cabantchik, William V. Breuer, Doron Aronson, Abeer Suleiman, Rachel Miller‐Lotan, Haim Hammerman, Andrew P. Levy · 2004 · Diabetes Care
14. Haemochromatosis genotype and iron overload: association with hypertension and left ventricular hypertrophy
    Christina Ellervik, Anne Tybjærg‐Hansen, Merete Appleyard, Hans Ibsen, Børge Grønne Nordestgaard · 2010 · Journal of Internal Medicine
15. Hyperinsulinemia may boost both hematocrit and iron absorption by up-regulating activity of hypoxia-inducible factor-1α
    Marya F. McCarty · 2003 · Medical Hypotheses
16. Haemochromatosis mutations and ferritin in myocardial infarction: a case‐control study
    Dirk Claeys, M. Walting, Friedgard Julmy, Walter Alfred Wuillemin, B. J. Meyer · 2002 · European Journal of Clinical Investigation
17. Blood donation, body iron status and carotid intima-media thickness
    Mariëlle F. Engberink, Johanna Marianne Geleijnse, Jane Durga, Dorine W. Swinkels, Wim L.A.M. de Kort, Evert G. Schouten, Petra Verhoef · 2007 · Atherosclerosis
18. High dose intravenous iron: a note of caution
    Josef Kletzmayr · 2002 · Nephrology Dialysis Transplantation
19. Mutations in the HFE Gene and Cardiovascular Disease Risk
    Daphne L. van der A, Maroeska Mariet Rovers, Diederick E. Grobbee, Joannes J.M. Marx, Jill Waalen, Christina Ellervik, B�rge G. Nordestgaard, John Kevin Olynyk, Peter R. Mills, James Shepherd et al. · 2008 · Circulation Cardiovascular Genetics
20. HFE mutations and risk of coronary heart disease in middle‐aged women
    D. L. van der A, Petra H. M. Peeters, Diederick E. Grobbee, Mark Roest, Joannes J.M. Marx, Hieronymus A.M. Voorbij, Yvonne T. van der Schouw · 2006 · European Journal of Clinical Investigation
21. Effects of Body Iron Stores and Haemochromatosis Genotypes on Coronary Heart Disease Outcomes in the Busselton Health Study
    C. J. Fox, Digby J Cullen, Matthew William Knuiman, G. N. Cumpston, Mark Divitini, Ezequiel Rossi, Peter Gochee, Lawrie W. Powell, John Kevin Olynyk · 2002 · European Journal of Cardiovascular Prevention & Rehabilitation
22. HFE Mutations as risk factors in disease
    Mark Worwood · 2002 · Best Practice & Research Clinical Haematology
23. Iron status in association with cardiovascular disease risk in 3 controlled feeding studies
    Jessica L Derstine, Laura E. Murray‐Kolb, Shaomei Yu-Poth, Rebecca L Hargrove, Penny M. Kris‐Etherton, John L. Beard · 2003 · American Journal of Clinical Nutrition
24. Fungal siderophores function as protective agents of LDL oxidation and are promising anti‐atherosclerotic metabolites in functional food
    Pócsi, István, Jeney, Viktória, Kertai, Pál, Pócsi, Imre, Emri, Tamás, Gyémánt, Gyöngyi, Fésüs, László, Balla, József, Balla, György · 2008 · Molecular Nutrition & Food Research
25. Iron deficiency anemia in heart failure
    Natasha Purai Arora, Jalal K. Ghali · 2012 · Heart Failure Reviews
26. Iron Stores and HFE Genotypes Are Not Related to Increased Risk of Ischemic Stroke
    Kim Ekblom, Johan Hultdin, Birgitta Stegmayr, Ingegerd Johansson, Bethany R. Van Guelpen, Göran Hallmans, Lars Weinehall, Lars Johansson, Per-Gunnar Wiklund, Stefan L. Marklund · 2007 · Cerebrovascular Diseases
27. A Room Temperature Ultrasensitive Magnetoelectric Susceptometer for Quantitative Tissue Iron Detection
    Hao Xi, Xiaoshi Qian, Meng-Chien Lu, Lei Mei, Sebastian Rupprecht, Qing Yang, Quan Zhang · 2016 · Scientific Reports
28. Efficacy and Safety of Iron Fortification
    Richard F. Hurrell · 2018 · Elsevier eBooks
29. Intravenous iron therapy in renal failure: Friend and foe?
    Behdad Afzali, David J.A. Goldsmith · 2004 · Journal of Nephrology
30. Mortality from ischaemic heart disease: sex-specific effects of transferrin saturation, serum iron, and total iron binding capacity. The HUNT study
    Bjørn Mørkedal, Lars E. Laugsand, Pål Romundstad, LARS JOHAN VATTEN · 2011 · European Journal of Cardiovascular Prevention & Rehabilitation
31. Non-transferrin-bound iron is associated with plasma level of soluble intercellular adhesion molecule-1 but not with in vivo low-density lipoprotein oxidation
    Lambertus J.H. van Tits, E. M. G. Jacobs, Dorine W. Swinkels, Heidi Lemmers, Gerly M. van der Vleuten, Jacqueline d Graaf, Anton F. H. Stalenhoef · 2006 · Atherosclerosis
32. Relationship between indices of iron status and coronary risk factors including diabetes and the metabolic syndrome in Saudi subjects without overt coronary disease
    Alissa, Eman M., Ahmed, Waqar H., Al-ama, Nabeel, Ferns, Gordon A.A. · 2007 · Journal of Trace Elements in Medicine and Biology
33. Evaluation of Essential Trace and Toxic Elements in Scalp Hair Samples of Smokers and Alcohol User Hypertensive Patients
    Hassan Imran Afridi, Dermot Brabazon, Tasneem Gul Kazi, Sumsun Naher · 2011 · Biological Trace Element Research
34. Association between Serum Ferritin and Circulating Oxidized Low-density Lipoprotein Levels in Patients with Type 2 Diabetes
    Yukio Ikeda, Tadashi Suehiro, Shigeo Yamanaka, Yoshitaka Kumon, Hiroshi Takata, Shojiro Inada, Naoko Ogami, Fumiaki Osaki, Mari Inoue, Kaoru Arii et al. · 2006 · Endocrine Journal
35. Iron Supplementation Does Not Affect the Susceptibility of LDL to Oxidative Modification in Women with Low Iron Status
    Amy E. Binkoski, Penny M. Kris‐Etherton, John L. Beard · 2004 · Journal of Nutrition
36. Iron status and the risk of coronary heart disease: an example of the use of nutritional epidemiology in chronic disease research
    Christopher T. Sempos, Anne C. Looker · 2001 · The Journal of Nutritional Biochemistry
37. Haemochromatosis gene mutations and risk of coronary heart disease: a west of Scotland coronary prevention study (WOSCOPS) substudy
    Ian R Gunn, F K Maxwell, Dairena F. Gaffney, Alex D. McMahon, Chris J. Packard · 2004 · Heart
38. Correction of Iron Deficiency in the Cardiorenal Syndrome
    Donald S. Silverberg, Dov Wexler, Adrian Iaina, Doron Schwartz · 2011 · International Journal of Nephrology
39. Iron Chelation and Vascular Function: In Search of the Mechanisms
    Ferrara, Dardo E., Taylor, W. Robert · 2005 · Arteriosclerosis, Thrombosis, and Vascular Biology
40. Environmental Toxins and the Heart
    Sahand Rahnama‐Moghadam, L. David Hillis, Richard A. Lange · 2014 · Elsevier eBooks
41. Dietary Iron Intake and Cardiovascular Outcome in Italian Women: 10-Year Follow-Up
    Edoardo Casiglia, Valérie Tikhonoff, Anna Bascelli, Nunzia Giordano, Sandro Caffi, Elisa Andreatta, Alberto Mazza, Giovanni Boschetti, Carla Grasselli, Mario Saugo et al. · 2011 · Journal of Women s Health
42. Low serum iron levels and risk of cardiovascular disease in high risk elderly population: Nested case–control study in the PREvención con DIeta MEDiterránea (PREDIMED) trial
    Mario Gutiérrez‐Bedmar, Pablo Olmedo, Fernando Gil, Miguel Ruiz‐Canela, Miguel Ángel Martínez‐González, Jordi Salas‐Salvadó, Nancy Babió, Montserrat Fitó, José Luis del Val García, Dolores Corella et al. · 2020 · Clinical Nutrition
43. The Iron-Heart Hypothesis
    Frank B. Hu · 2007 · JAMA
44. Dietary iron intakes and elevated iron stores in the elderly: is it time to abandon the set-point hypothesis of regulation of iron absorption?
    John Beard · 2002 · American Journal of Clinical Nutrition
45. Towards high‐siderophore‐content foods: optimisation of coprogen production in submerged cultures of Penicillium nalgiovense
    Tamás Emri, Viktória Tóth, Csilla Terézia Nagy, Gábor Nagy, Imre Pócsi, Gyöngyi Gyémánt, Károly Antal, József Balla, György Balla, Gyula Román et al. · 2012 · Journal of the Science of Food and Agriculture
46. Plasma ferritin levels, genetic variations in HFE gene, and coronary heart disease in Chinese: A case–control study
    Y. Shi, Li Zhou, Lihong Huang, Y.T. Lian, X.M. Zhang, Huan Guo, Tangchun Wu, Lihua Cheng, Meian He · 2011 · Atherosclerosis
47. Treatment of Anemia in Heart Failure
    Qurat‐ul‐ain Jelani, Stuart D. Katz · 2010 · Cardiology in Review
48. A preliminary investigation of the association between haptoglobin polymorphism, serum ferritin concentration and fatty liver disease
    Takehiro Nakagawa, Yosuke Muramoto, Masaharu Hori, 三原 修一, Toru Marubayashi, Kazuko Nakagawa · 2008 · Clinica Chimica Acta
49. Iron
    Marianne Wessling‐Resnick · 2016 · Elsevier eBooks
50. Serum iron, infection and inflammation; effects on coronary risk
    Helena Kervinen, Leena Tenkanen, Timo Palosuo, Merja Roivainen, Vesa Manninen, Matti Mänttäri · 2004 · Scandinavian Cardiovascular Journal
51. Dietary iron intake and risk of non-fatal acute myocardial infarction
    Alessandra Tavani, Silvano Gallus, Cristina Bosetti, Maria Teresa Parpinel, Eva Negri, Carlo La Vecchia · 2006 · Public Health Nutrition
52. Reduced metal ion concentrations in atherosclerotic plaques from subjects with Type 2 diabetes mellitus
    Nadina Stadler, Sylvia Heeneman, Stefan Adrian Vöö, Naomi Stanley, Gregory Ian Giles, Bevan P. Gang, Kevin D. Croft, Trevor Anthony Mori, Vladimir Vacata, Mat J.A.P. Daemen et al. · 2012 · Atherosclerosis
53. Iron and cardiac ischemia: a natural, quasi‐random experiment comparing eligible with disqualified blood donors (CME)
    Marc Germain, Gilles Delage, Claudia Blais, Elizabeth Maunsell, Francine Décary, Yves Grégoire · 2013 · Transfusion
54. Increased iron stores prolong the QT interval – a general population study including 20 261 individuals and meta‐analysis of thalassaemia major
    Lise Henriksen, Anne Petri, Hans Carl Hasselbalch, Jørgen Kim Kanters, Christina Ellervik · 2016 · British Journal of Haematology
55. Association of serum ferritin with coronary artery disease
    Yunping Zhou, Tongtao Liu, Changwei Tian, Peipei Kang, Chongqi Jia · 2012 · Clinical Biochemistry
56. Increased oxidative stress and altered serum macro-minerals and trace elements levels are associated with coronary artery disease
    Tasnim Fariha Noshin, Md. Ramjan Ali, Sujan Banik · 2020 · Journal of Trace Elements in Medicine and Biology
57. Iron and Atherosclerosis: Nailing Down a Novel Target with Magnetic Resonance
    Travis Sharkey‐Toppen, Arun Kumar Tewari, Subha V. Raman · 2014 · Journal of Cardiovascular Translational Research
58. Dose-dependent effect of parenteral iron therapy on bleomycin-detectable iron in immune apheresis patients
    Gürkan Sengoelge, Verena Rainer, Josef Kletzmayr, Martin Jansen, Kurt Derfler, Manuela Födinger, Walter Hermann Hörl, Gere Sunder–Plassmann · 2004 · Kidney International
59. Can excess iron increase the risk for coronary heart disease and cancer?
    Colette N. M. Kelly · 2002 · Nutrition Bulletin
60. Effects of body iron stores and haemochromatosis genotypes on coronary heart disease outcomes in the Busselton health study
    Christopher Fox, Digby J Cullen, Matthew William Knuiman, G. N. Cumpston, Mark Divitini, Enrico Rossi, Peter Gochee, Lawrie W. Powell, John Kevin Olynyk · 2002 · Journal of Cardiovascular Risk
61. Association between iron status and incident coronary artery disease: a population based-cohort study
    Shuren Guo, Xiaohuan Mao, Xiaohua Li, Huan Ouyang · 2022 · Scientific Reports
62. Effects of one year simvastatin and atorvastatin treatments on acute phase reactants in uncontrolled type 2 diabetic patients
    Kubilay Ükinç, Halil Önder Ersöz, Cihangir Erem, Arif Hacıhasanoğlu, Suleyman Sami Karti · 2009 · Endocrine
63. Hemochromatosis (HFE) genotype and atherosclerosis: Increased susceptibility to iron-induced vascular damage in C282Y carriers?
    Mariëlle F. Engberink, Cécile M Povel, Jane Durga, Dorine W. Swinkels, Wim L.A.M. de Kort, Evert G. Schouten, Petra Verhoef, Johanna Marianne Geleijnse · 2010 · Atherosclerosis
64. Iron and Heart Disease
    Christopher T. Sempos, Richard Frank Gillum, Anne C. Looker · 2005 · Humana Press eBooks
65. Relationship of Lipid Profile and Serum Ferritin levels with Acute Myocardial Infarction
    Shipra, Bharat Kumar Gupta, Ranjan Solanki, Himanshu Punia, Vibhuti Agarwal, Jaskiran Kaur, Ashish Kumar Shukla · 2014 · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
66. Tolerable upper intakes for dietary iron set by the US Food and Nutrition Board
    Klaus Schümann, Berit Borch‐Iohnsen, Matthias W. Hentze, Joannes J.M. Marx · 2002 · American Journal of Clinical Nutrition
67. Novel loci and biomedical consequences of iron homoeostasis variation
    Elias Allara, Steven Bell, Rebecca Smith, Spencer J. Keene, Dipender Gill, Liam Gaziano, Deisy Morselli Gysi, Feiyi Wang, Vinicius Tragante, Amy M. Mason et al. · 2024 · Communications Biology
68. Prevention of coronary heart disease
    Philip R. Liebson, Ezra A. Amsterdam · 2000 · Disease-a-Month
69. Role of non-transferrin-bound iron in chronic renal failure and other disease conditions
    Mungli Prakash · 2007 · Indian Journal of Nephrology
70. Human Health Significance of Dietary Exposures to Methylmercury
    Anna L. Choi, Philippe Grandjean · 2011 · Wiley eBooks
71. Design and Rationale for the Study of Changes in Iron and Atherosclerosis Risk in Perimenopause
    Georgeta Mihai, Xin He, Xiaolan Zhang, Beth Mc Carthy, Tam Tran · 2011 · Journal of Clinical & Experimental Cardiology
72. Influence of blood donation time intervals on ferritin and hemoglobin concentration
    Aura R. Manascero-Gómez, Melisa Bravo-Espinosa, Katherine Solano-Muriel, Raúl A. Poutou‐Piñales · 2015 · Transfusion and Apheresis Science
73. Nuclear microscopy of atherosclerotic tissue: A review
    F. Watt, Minqin Ren, J.P Xie, B.K.H. Tan, Barry B. Halliwell · 2001 · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms
74. Serum non-transferrin-bound iron and low-density lipoprotein oxidation in heterozygous hemochromatosis
    Lambertus J.H. van Tits, Esther M. G. Jacobs, Dorine W. Swinkels, Heidi Lemmers, Gerly M. van der Vleuten, Jacqueline d Graaf, Anton F. H. Stalenhoef · 2006 · Biochemical and Biophysical Research Communications
75. Serum ferritin and transferrin receptor concentrations during the transition from adolescence to adulthood in a healthy Swedish population
    G Samuelson, Bo L Lönnerdal, BR Kempe, J‐E Elverby, L.‐E. Bratteby · 2003 · Acta Paediatrica
76. Urinary Catalytic Iron in Obesity
    Tina Kaur Thethi, Kaushik Parsha, Mohan M. Rajapurkar, Banibrata N. Mukhopadhyay, Sudhir V. Shah, C. Lillian Yau, Shanker Japa, Vivian Andrew Fonseca · 2010 · Clinical Chemistry
77. Trace elemental distributions in induced atherosclerotic lesions using nuclear microscopy
    Ren Minqin, F. Watt, Benny Tan Kwong Huat, Barry B. Halliwell · 2003 · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms
78. REVIEW PAPER Do changes in iron metabolism contribute to the acceleration of the atherosclerosis process?
    Dorota Formanowicz · 2014 · Biotechnologia
79. Factor analysis of risk variables associated with iron status in patients with coronary artery disease
    Vesna Spasojević‐Kalimanovska, Nataša Bogavac‐Stanojević, Dimitra Kalimanovska‐Oštrić, Lidija Memon, Slavica Spasić, Jelena Kotur‐Stevuljević, Zorana Jelić‐Ivanović · 2014 · Clinical Biochemistry
80. HUMAN NUTRITION | Cardiovascular and Obesity Health Concerns
    Lars Ovesen · 2004 · Elsevier eBooks
81. Thyroid Function and Serum Ferritin Levels: The Study of Health in Pomerania
    Henry Völzke, Henri Wallaschofski, Birger Wolff, Klaus Berger, Ulrich John, Marcus Dörr · 2006 · Thyroid
82. Risk of iron overload in carriers of genetic mutations associated with hereditary haemochromatosis: UK Food Standards Agency workshop.
    Mamta K. Singh, Margaret Ashwell, Peter Sanderson, Janet Elizabeth Cade, Jennifer A. Moreton, Susan Jane Fairweather‐Tait, Mark A. Roe, Joannes J.M. Marx, Mark Worwood, James D. Cook · 2006 · PubMed
83. Surcharges en fer d’origine génétique et hépatosidérose dysmétabolique
    M. Ruivard · 2008 · La Revue de Médecine Interne
84. Targeting Iron Deficiency Anemia in Heart Failure
    Tajinderpal Saraon, Stuart D. Katz · 2015 · Progress in Cardiovascular Diseases
85. Iron status and cardiovascular disease risk in black South African women: the PURE study
    Olaide Ruth Aderibigbe, Pt Pisa, RL Mamabolo, Herculina Salome Kruger, HH Vorster, Ankebé Kruger · 2011 · South African Journal of Clinical Nutrition
86. The Mediterranean Diet and Coronary Heart Disease
    Antonia-Leda Matalas, Antonis Zampelas, Vassilis Stavrinos · 2001 · CRC Press eBooks
87. Iron and Heart Disease: A Review of the Epidemiologic Data
    Christopher T. Sempos, Anne C. Looker, Daniel McGee, Jürgen T. Rehm · 2009 · Humana Press eBooks
88. Iron status and clinical outcome in patients with coronary artery disease after coronary stenting
    Gjin Ndrepepa, Siegmund Braun, Alban Dibra, Julinda Mehilli, Wolfgang Vogt, Albert Schömig, Adnan Kastrati · 2005 · Nutrition Metabolism and Cardiovascular Diseases
89. Associations Between Hemoglobin and Serum Iron Levels and the Risk of Mortality Among Patients with Coronary Artery Disease
    Qing Li, Zhijun Pan, Yupeng Zeng, Xu Wang, Dan Li, Ting Yin, Qian Chen, Wenhua Ling · 2024 · Nutrients
90. Association between trace elements and metabolic syndrome among type 2 diabetes mellitus patients in Gorgan
    Abdoljalal Marjani, Fateme Ali Akbari, Samira Eshghinia · 2015
91. [Increased iron store and its relationship with cardiovascular disease].
    Tomás Meroño, Patricia Beatriz Sorroche, Fernando Daniel Brites · 2011 · PubMed
92. Risiken und Nutzen der Eisensupplementation: Empfehlungen zur Eisenaufnahme kritisch betrachtet
    Klaus Schümann, T. Ettle, Bernadett Szegner, Bernd Elsenhans, Noel W. Solomons · 2013 · Perspectives in Medicine
93. An ultrasensitive magnetoelectric sensor system for the quantitative detection of liver iron
    Hao Xi, Lu Meng-Chien, Xiaoshi Qian, Quan Zhang, Sebastian Rupprecht, Qing Yang · 2016 · Proceedings of IEEE Sensors/Proceedings of IEEE Sensors ...
94. Iron hypothesis and coronary artery disease in geriatric patients
    Hossein Mokhtari, Babak Bagheri, Mehdi Rasouli · 2018 · Archives of Physiology and Biochemistry
95. Iron: Tolerable Upper Intake Levels
    Reprinted from IOM Report on DRIs for Micronutrients · 2002 · Nutrition in Clinical Care
96. Iron
    Klaus Schümann, Bernd Elsenhans · 2004
97. Increased Levels of Circulating Iron-Albumin Complexes in Peripheral Arterial Disease Patients
    Elisabetta Schiano, Enrico Cappello, Domenico Cecere, Francesco Pompeo, Ettore Novellino, Mariano Stornaiuolo, Marcello Izzo · 2023 · Antioxidants
98. Association Of Serum Ferritin And Cardiovascular Risk Factors: A Cross-Sectional Analysis Of Data From The Third National Health And Nutrition Examination Survey
    2005 · The Internet Journal of Epidemiology
99. Preparatory work for the update of the tolerable upper intake levels for iron
    Alexandr Parlesak, Talia Masino, Kia Daniela Reis, Caroline Filskov Petersen, Jacob Juel Christensen, Thomas Olsén, Inge Tetens · 2024 · EFSA Supporting Publications
100. Leites e Fórmulas Infantis: a realidade portuguesa revisitada em 2012
     Carla Rêgo, Andreia Teles, Margarida Nazareth, António Guerra · 2013 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)